Nima Farzan is CHIEF EXECUTIVE OFFICER of Kinnate Biopharma Inc.. Currently has a direct ownership of 0 shares of KNTE, which is worth approximately $0. The most recent transaction as insider was on Apr 03, 2024, when has been sold 2,186 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Nima Farzan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 03 2024
SELL
Sale (or disposition) back to the issuer
-
2,186 Reduced 100.0%
0 Common Stock

Also insider at

KROS
Keros Therapeutics, Inc. Healthcare
NF

Nima Farzan

CHIEF EXECUTIVE OFFICER
Lexington, MA

Track Institutional and Insider Activities on KNTE

Follow Kinnate Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNTE shares.

Notify only if

Insider Trading

Get notified when an Kinnate Biopharma Inc. insider buys or sells KNTE shares.

Notify only if

News

Receive news related to Kinnate Biopharma Inc.

Track Activities on KNTE